FDA Announces Seizure of Wisconsin Supplements for False Claims, Etc.
The Food and Drug Administration reports that on December 1, 2011, U.S. Marshals seized at its request all dietary supplements by a Wisconsin maker for false claims made about their safety and effectiveness in treating diseases such as asthma, cardiovascular…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
disease, cataracts, glaucoma and infections. The products are not FDA-approved as safe and effective for treating any diseases. According to the complaint, the company also failed to follow the current good manufacturing practice (cGMP) requirements for dietary supplements, as required by federal law.